Furthermore, the regulatory effect of VCAM-1 activation and cross-linking on multiple signalling pathways—including vascular permeability [33], angiogenesis [42, 74], and anti-apoptosis [62]—also explains the broad involvement of the protein in both IBD and CRC despite the pathophysiological differences between the two diseases. Here, VCAM1 is linked to colorectal carcinoma.